Spanning nearly 100 laboratories in 45 countries, landmark research has, for the first time, shown an association between genetic brain size and neurological conditions such as Parkinson’s disease and attention-deficit/hyperactivity disorder (ADHD). And while it doesn’t prove causation, it’s a big step forward in being able to assess risk factors and provide early intervention.